Announced Thu, 15 Oct, 2026 · 14:46 IST

RTA Compliance Certificate for Quarter Ended September 2026

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.0%Reaction day

₹1.80

prior close

₹1.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+1.6% vs market

Trading & Distributors peers, median of 134sector+0.0%+0.0% vs sector

On the reaction day the stock moved 1.6 pts more than Nifty Microcap 250 and in line with its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.0-1.6+1.6+0.0+0.0

Next day

+5.0-1.0+6.0+0.0+5.0

+8.3-2.6+10.9-1.0+9.3

—-5.1—-2.0—

+3.3-6.1+9.5-3.6+6.9

—-8.3—-5.4—

-6.1-6.4+0.2-3.9-2.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Trading & Distributors peers, median of 134Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Evoq Remedies submitted a routine compliance certificate from its Registrar under SEBI Regulation 74(5) for the quarter ended September 30, 2026. The RTA confirms all dematerialization requests were processed within stipulated timelines. Filing was signed by Resolution Professional Dipti Narayan Mundra, indicating ongoing insolvency proceedings. No material business update.

Likely market impact

Routine compliance filing; no material business impact. Company remains under insolvency resolution process.